Measure Title FOLLOW UP EXAMINATION AFTER DIAGNOSIS AND TREATMENT OF SKIN CANCERS Disease State Cancer Indicator Classification Disease Management

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Measure Title FOLLOW UP EXAMINATION AFTER DIAGNOSIS AND TREATMENT OF SKIN CANCERS Disease State Cancer Indicator Classification Disease Management"

Transcription

1 Client HMSA: PQSR 2009 Measure Title FOLLOW UP EXAMINATION AFTER DIAGNOSIS AND TREATMENT OF SKIN CANCERS Disease State Cancer Indicator Classification Disease Management Strength of Recommendation Organizations Providing Recommendation Clinical Intent Physician Specialties (suggested) Background B American Academy of Dermatology British Association of Dermatologists British Association of Plastic Surgeons Melanoma Study Group National Cancer Institute National Comprehensive Cancer Network To ensure that all members who have been diagnosed with skin cancer receive the appropriate follow up at least annually. Refer to PQSR 2009 Clinical Measures by Specialty. Disease Burden The American Cancer Society estimates that 61,290 people will be newly diagnosed with melanoma in 2006, making melanoma the fifth and sixth most common cancer among men and women, respectively.[1] In addition, more than 1 million cases of cutaneous basal cell or squamous cell cancers occur yearly.[1] Approximately 10,710 people will die from skin cancer in 2006, and it is estimated that 7,910 of those deaths will be from melanoma.[1] Melanoma is a leading cause of cancer death in the United States. The lifetime risk for dying of melanoma is 0.36 percent in white men and 0.21 percent in white women. Men older than age 65 account for 22 percent of the newly diagnosed cases of malignant melanoma each year and women in the same age group account for 14 percent. While basal cell and squamous cell carcinomas are more than 10 times as common as melanoma they account for less morbidity and mortality. Squamous cell cancers, are resposible for 20 percent of all deaths from skin cancer.[2] Reason for Indicated Intervention or Treatment Surveys of cancer and melanoma registries demonstrate that patients diagnosed with cutaneous melanoma have a % incidence of developing a second primary melanoma after the initial diagnosis [3 9], a risk that is times greater than for

2 patients without a history of melanoma.[4, 5] Rates of recurrence are approximately 20%.[10 12] The greatest risk of developing a new or recurrent melanoma is in the first or second year after the initial diagnosis.[12 15] Patients with cutaneous squamous cell or basal cell carcinomas have at least a 10 fold increase in incidence of developing a subsequent cancer of the same type [16], and almost 50% of patients treated for squamous or basal cell carcinoma have another skin cancer within 5 years.[17 19] Approximately 95% of the recurrences and metastases of cutaneous squamous cell carcinoma occur during the first five years after treatment.[20] Evidence supporting Intervention or Treatment Studies are mixed on whether patients or physicians detect more new or recurrent melanomas at follow up. While some studies show that patients detect recurrences more frequently than their physicians (47 72%) [10 12], others indicate that physicians have a higher rate of detection.[12, 21] A prospective intervention study of 9000 patients diagnosed with melanoma from 1971 to 1999 showed that careful patient followup (biannually for the first five years and annually thereafter) allowed for earlier diagnosis of a second primary melanoma, since the tumor stage for the second melanoma was significantly lower than for the first.[22] However, one audit of 331 melanoma patients with recurrences indicated that even though physicians detected recurrences at earlier stages than patients, no changes in survival were seen between the two groups.[11] Cancers diagnosed at earlier stages are more likely to be curable, and the evidence suggests that follow up of patients with skin cancer may be important in detecting new and recurrent cancers. Unfortunately, no studies directly examine the relationship between follow up intervals for melanoma [12 14], squamous cell carcinoma, or basal cell carcinoma and patient outcomes. Clinical Recommendation The American Academy of Dermatology (AAD), based on recommendations from a task force of recognized experts, recognizes that there is no evidence to support a specific follow up interval for patients with primary cutaneous melanoma. However, the AAD recommends routine interval follow up physical examinations at least annually.[23] The Melanoma Study Group and the British Association of Dermatologists recommend 3 month visits for 3 years for all patients with invasive melanoma. Thereafter, those with melanomas greater than 1.0 mm in depth should be followed every 6 months for another 2 years, while those with melanomas

3 less than 1.0 mm in depth do not require further follow up. Patients with in situ melanoma need only one follow up after complete excision of the primary lesion.[10, 24] For squamous cell carcinoma, the British Association of Dermatologists, the British Association of Plastic Surgeons and the Faculty of the Clinical Oncology of the royal College of Radiologists recommend that patients be kept under observation for 5 years by a specialist, primary care physician or patient self examination.[25] The American Academy of Dermatology recommends either annual or biannual screening for all patients with a history of nonmelanoma skin cancers.[26] The National Cancer Institute recommended that individuals with basal cell carcinoma be clinically examined every 6 months for 5 years. Thereafter, patients should be examined for recurrent tumors or new primary tumors at yearly intervals. In addition, since squamous cell carcinomas have significant potential for metastasis, patients should be re examined every 3 months for the first several years and then followed indefinitely at 6 month intervals.[27] NCCN Practice Guidelines in Oncology state that individuals with a diagnosis of melanoma or non melanoma skin cancer (e.g., basal cell carcinoma or squamous cell carcinoma) should be clinically examined at least yearly for life.[28] The American Society of Plastic Surgeons recommends a follow up physical exam including full skin assessment and lymph node palpation every 3 months for the first year, then every 6 months for 5 years, and then yearly thereafter (Level of Recommendation: B).[29] Source Denominator Denominator Definition Health Benchmarks, Inc Continuously enrolled members ages years by the end of the measurement year, who had a skin biopsy followed by a diagnosis of skin cancer during the year prior to the measurement year. Denominator Exclusion Denominator Members with a diagnosis of malignant neoplasm of the vagina, labia Exclusion majora, labia minora, vulva unspecified, prepuce, skin of the breast, any Definition carcinoma in situ of breast and genitourinary system, or neoplasm of bone, soft tissue, or skin during the days after the index date. Numerator Numerator Definition Members who had at least 1 follow up visit or a procedure removing a benign or pre malignant skin lesion within days after the index date.

4 Physician Attribution Physician Score all physicians (in the selected specialties) who saw the member on Attribution index date or from days after the index date. Description References 1. American Cancer Society, Cancer Facts and Figures , American Cancer Society: Atlanta, GA. 2. Saraiya, M., et al., Preventing skin cancer: findings of the Task Force on Community Preventive Services On reducing Exposure to Ultraviolet Light. MMWR Recomm Rep, (RR 15): p Goggins, W.B. and H. Tsao, A population based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer, (3): p DiFronzo, L.A., et al., Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol, (7): p Wassberg, C., et al., Second primary cancers in patients with cutaneous malignant melanoma: a population based study in Sweden. Br J Cancer, (2): p Veronesi, U., N. Cascinelli, and R. Bufalino, Evaluation of the risk of multiple primaries in malignant cutaneous melanoma. Tumori, (1): p Brobeil, A., et al., Multiple primary melanomas: implications for screening and follow up programs for melanoma. Ann Surg Oncol, (1): p Levi, F., et al., Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer, (5): p Slingluff, C.L., Jr., R.T. Vollmer, and H.F. Seigler, Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery, (3): p Dicker, T.J., et al., A rational approach to melanoma follow up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol, (2): p Baughan, C.A., et al., Follow up in stage I cutaneous malignant melanoma: an audit. Clin Oncol (R Coll Radiol), (3): p Poo Hwu, W.J., et al., Follow up recommendations for patients with American Joint Committee on Cancer Stages I III malignant melanoma. Cancer, (11): p Martini, L., et al., First recurrence analysis of 840 cutaneous melanomas: a proposal for a follow up schedule. Tumori, (3): p Kelly, J.W., M.S. Blois, and R.W. Sagebiel, Frequency and duration of patient follow up after treatment of a primary malignant melanoma. J Am Acad Dermatol, (5 Pt 1): p

5 15. Savoia, P., et al., Multiple primary melanomas: analysis of 49 cases. Melanoma Res, (4): p Marcil, I. and R.S. Stern, Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta analysis. Arch Dermatol, (12): p Marghoob, A., et al., Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol, (1): p Frankel, D.H., B.H. Hanusa, and J.A. Zitelli, New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow up. J Am Acad Dermatol, (5 Pt 1): p Karagas, M.R., et al., Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. Jama, (24): p Rowe, D.E., R.J. Carroll, and C.L. Day, Jr., Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol, (6): p Basseres, N., et al., Cost effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10 year experience in a dermatology department in France. Dermatology, (3): p DiFronzo, L.A., L.A. Wanek, and D.L. Morton, Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow up. Cancer, (8): p Sober, A.J., et al., Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol, (4): p Roberts, D.L., et al., U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol, (1): p Motley, R., P. Kersey, and C. Lawrence, Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol, (1): p Guidelines of care for cutaneous squamous cell carcinoma. Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. J Am Acad Dermatol, (4): p Basal Cell Carcinoma of the Skin. Skin Cancer (PDQ) Treatment 2007 July 18, 2007 [cited; Available from: rofessional/page National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Melanoma V : p Evidence based clinical practice guideline: treatment of cutaneous

6 melanoma. 2007, American Society of Plastic Surgeons: Arlington Heights, IL. p Health Benchmarks and HMSA. All rights reserved.

Umass Medical School Division of Dermatology

Umass Medical School Division of Dermatology Basal Cell and Squamous Cell Carcinoma Dori Goldberg, MD Umass Medical School Division of Dermatology Basal and squamous cell carcinoma Definition The most common types of skin cancer Excluding melanoma,

More information

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Skin Cancer: The Facts Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario. Types of skin Cancer Basal cell carcinoma (BCC) most common

More information

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500

More information

CONTENTS 1. EXECUTIVE SUMMARY... 49

CONTENTS 1. EXECUTIVE SUMMARY... 49 SKIN CANCER This working paper has been prepared by Mr D W Patton, Consultant/Honorary Senior Lecturer in Maxillofacial Surgery, School of Postgraduate Studies in Medical and Health Care, Morriston Hospital,

More information

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006 Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd

More information

Report with statistical data from 2007

Report with statistical data from 2007 2008 Cancer Program Annual Report with statistical data from 2007 Lake Cumberland Regional Hospital 305 Langdon Streett Somerset, KY 42503 Telephone: 606-679-7441 Fax: 606-678-9919 Cancer Committee Mullai,

More information

PET/CT for Melanoma. Sarajevo (Bosnia & Hercegovina) Wednesday, June :40 10:20

PET/CT for Melanoma. Sarajevo (Bosnia & Hercegovina) Wednesday, June :40 10:20 Sarajevo (Bosnia & Hercegovina) Wednesday, June 18 2014 09:40 10:20 PET/CT for Melanoma The Trundholm Sun Chariot, anterior view app 1350 BC The National Museum of Denmark, Copenhagen 54 x 35 x 29 cm (width,

More information

Cancer Staging. Introduction. Overview

Cancer Staging. Introduction. Overview Many Hearts Many Minds One Goal Volume 2 Number 3 May 2005 Cancer Staging bt Maureen MacIntyre, Director, Surveillance and Epidemiology Unit, Cancer Care Nova Scotia and Dr. Eva Grunfeld, Clinician Scientist

More information

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Cancer in Ireland 2013: Annual report of the National Cancer Registry Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)

More information

TNM Staging Fact Sheet

TNM Staging Fact Sheet TNM Staging Fact Sheet Jan 2010 This document provides answers to some of the frequently asked questions posed by physicians, health information management professionals, and cancer program administrators,

More information

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N.

COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N. ISSN 1744-6783 COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N. Tanaka Business School Discussion Papers: TBS/DP05/39 London: Tanaka Business School, 2005 1 Cost of skin cancer in

More information

Nurse Practitioner, Dermatology

Nurse Practitioner, Dermatology Melissa O Neill, O MS, APRN Nurse Practitioner, Dermatology Three Types of Skin Cancer > Basal Cell Carcinoma > Squamous Cell Carcinoma > Malignant Melanoma Basal Cell Carcinoma > Most common skin cancer

More information

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

OBJECTIVES By the end of this segment, the community participant will be able to:

OBJECTIVES By the end of this segment, the community participant will be able to: Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway

More information

Malignant Melanoma Early Stage. A guide for patients

Malignant Melanoma Early Stage. A guide for patients This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University

More information

Secondary Cancer Rates Following Breast Cancer Diagnosis

Secondary Cancer Rates Following Breast Cancer Diagnosis Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:98 106 ORIGINAL RESEARCH Secondary Cancer Rates Following Breast Cancer Diagnosis David Wesley, MD Life table analysis and other mortality

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening The American Cancer Society and Congregational Health Ministry Team October Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry

More information

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of

More information

The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006

The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy

More information

Skin Cancer in Organ Transplant Recipients. Dana Baran, M.D. FRCPC Manish Khanna, M.D. FRCPC

Skin Cancer in Organ Transplant Recipients. Dana Baran, M.D. FRCPC Manish Khanna, M.D. FRCPC Skin Cancer in Organ Transplant Recipients Dana Baran, M.D. FRCPC Manish Khanna, M.D. FRCPC Skin Cancer in Transplant Recipients Skin cancers are the most frequent malignancies after organ transplantation

More information

Sustaining a High-Quality Breast MRI Practice

Sustaining a High-Quality Breast MRI Practice Sustaining a High-Quality Breast MRI Practice Christoph Lee, MD, MSHS Associate Professor of Radiology Adjunct Associate Professor, Health Services University of Washington September 11, 2015 Overview

More information

Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.

Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors. Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)

More information

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What? RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which

More information

Askin biopsy may be performed for either. The Vanishing Biopsy: The Trend Toward Smaller Specimens THERAPEUTICS FOR THE CLINICIAN

Askin biopsy may be performed for either. The Vanishing Biopsy: The Trend Toward Smaller Specimens THERAPEUTICS FOR THE CLINICIAN THERAPEUTICS FOR THE CLINICIAN The Vanishing Biopsy: The Trend Toward Smaller Specimens Emmy M. Fernandez, MD; Thomas Helm, MD; Michael Ioffreda, MD; Klaus F. Helm, MD Dermatopathologists have noted an

More information

General Information on Mammography and Breast Cancer Screening

General Information on Mammography and Breast Cancer Screening General Information on Mammography and Breast Cancer Screening General Information on Mammography and Breast Cancer Screening You have made an appointment with your doctor for a mammogram. If this is your

More information

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)

More information

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening. CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests

More information

Theories on Metastasis: Innovative Thinking An Advocacy Perspective

Theories on Metastasis: Innovative Thinking An Advocacy Perspective Theories on Metastasis: Innovative Thinking An Advocacy Perspective Project LEAD Workshop NBCC Annual Advocacy Conference 2011 Musa Mayer AdvancedBC.org 1 The Big Question If we want to end death from

More information

Monitoring Clinical Stage to Improve Care

Monitoring Clinical Stage to Improve Care Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,

More information

Ovarian Cancer. Andreas Obermair. Gynaecological Oncologist

Ovarian Cancer. Andreas Obermair. Gynaecological Oncologist Ovarian Cancer Andreas Obermair Gynaecological Oncologist www.obermair.info Ovarian cancer in QLD Five patients with ovarian cancer per week in QLD. Two patients will be diagnosed in early stage (stage

More information

Progress and Prospects in Ovarian Cancer Screening and Prevention

Progress and Prospects in Ovarian Cancer Screening and Prevention Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian

More information

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information

More information

METROPOLITAN LIFE INSURANCE COMPANY NEW YORK, NEW YORK

METROPOLITAN LIFE INSURANCE COMPANY NEW YORK, NEW YORK METROPOLITAN LIFE INSURANCE COMPANY NEW YORK, NEW YORK POLICYHOLDER: Your Employer Group Policy Form No: GPNP14-CI (Referred to as the Group Policy ) Certificate Form No: GCERT14-CI (Referred to as the

More information

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D. Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are

More information

The Ontario Cancer Registry moves to the 21 st Century

The Ontario Cancer Registry moves to the 21 st Century The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer

More information

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center Cancer is a group of more than 100 related diseases. Normally, cells grow and divide to produce more cells to keep the body healthy. Sometimes, this process goes wrong. New cells form when the body doesn

More information

The Triad Breast Cancer Screening. Mary Helen Hackney, MD FACP VCU Massey Cancer Center March 2016

The Triad Breast Cancer Screening. Mary Helen Hackney, MD FACP VCU Massey Cancer Center March 2016 The Triad Breast Cancer Screening Mary Helen Hackney, MD FACP VCU Massey Cancer Center March 2016 I have no financial disclosures I am a medical oncologist with a practice focused on breast cancer The

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

EYELID SKIN CANCER. Speakers Bureau Series

EYELID SKIN CANCER. Speakers Bureau Series Speakers Bureau Series EYELID SKIN CANCER By Leslie M Sims, MSPH, MD, FAAO Board Certified Ophthalmologist The Sims Center for Eyelid and Facial Aesthetics 1 Most Common Eyelid Skin Cancers: Basal Cell

More information

PROPOSAL GRADUATE CERTIFICATE ADVANCED PRACTICE ONCOLOGY SCHOOL OF NURSING TO BE OFFERED AT PURDUE UNIVERSITY WEST LAFAYETTE CAMPUS

PROPOSAL GRADUATE CERTIFICATE ADVANCED PRACTICE ONCOLOGY SCHOOL OF NURSING TO BE OFFERED AT PURDUE UNIVERSITY WEST LAFAYETTE CAMPUS Graduate Council Document 08-20b Approved by the Graduate Council November 20, 2008 PROPOSAL GRADUATE CERTIFICATE ADVANCED PRACTICE ONCOLOGY SCHOOL OF NURSING TO BE OFFERED AT PURDUE UNIVERSITY WEST LAFAYETTE

More information

hoosier stories of success in cancer prevention & control

hoosier stories of success in cancer prevention & control The ICC is proud of the accomplishments of our partner organizations, and is aware of the impact these accomplishments have in saving lives and building a sustainable direction for cancer prevention and

More information

Dr. Stefaan Van de Perre Dr. An Belmans. Dienst Radiologie. H. Hartziekenhuis Mol A.Z. St.-Dimpna Geel

Dr. Stefaan Van de Perre Dr. An Belmans. Dienst Radiologie. H. Hartziekenhuis Mol A.Z. St.-Dimpna Geel Dr. Stefaan Van de Perre Dr. An Belmans Dienst Radiologie H. Hartziekenhuis Mol A.Z. St.-Dimpna Geel 1 Background Screening trials harms and benefits Practical guidelines Take home messages 2 Background

More information

Together, The Strength

Together, The Strength DECATUR County Indiana Together, The Strength to Fight Cancer Barbara Taylor, MD Cancer Committee Chairperson Rahul Dewan, DO Radiation Oncology Cancer Liasion Jaime Ayon, MD Medical Oncology/ Hematology

More information

The third all breast cancer report

The third all breast cancer report The third all breast cancer report Back to basics: Breast cancer incidence and mortality West Midlands Knowledge and Intelligence Team, Public Health England and the National Cancer Intelligence Network

More information

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:

More information

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer The Importance of Cervical Screening and Vaccination Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this

More information

Neoadjuvant radiotherapy: Necessary for treatment of rectal cancer. Shannon Acker April 4, 2011

Neoadjuvant radiotherapy: Necessary for treatment of rectal cancer. Shannon Acker April 4, 2011 Neoadjuvant radiotherapy: Necessary for treatment of rectal cancer Shannon Acker April 4, 2011 Rectal Cancer 40,870 new cases in the US in 2009 49,920 deaths from colorectal cancer Second leading cause

More information

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women

More information

4/8/13. Pre-test Audience Response. Prostate Cancer 2012. Screening and Treatment of Prostate Cancer: The 2013 Perspective

4/8/13. Pre-test Audience Response. Prostate Cancer 2012. Screening and Treatment of Prostate Cancer: The 2013 Perspective Pre-test Audience Response Screening and Treatment of Prostate Cancer: The 2013 Perspective 1. I do not offer routine PSA screening, and the USPSTF D recommendation will not change my practice. 2. In light

More information

LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE V. MALIGNANT LYMPHOMA, FIBROSARCOMA, MALIGNANT MELANOMA, AND OSTEOGENIC SARCOMA

LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE V. MALIGNANT LYMPHOMA, FIBROSARCOMA, MALIGNANT MELANOMA, AND OSTEOGENIC SARCOMA LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE V. MALIGNANT LYMPHOMA, FIBROSARCOMA, MALIGNANT MELANOMA, AND OSTEOGENIC SARCOMA IRA T. NATHANSON,l M.D., AND CLAUDE E. WELCH,2 M.D. (From the Collis P.

More information

Early Prostate Cancer: Questions and Answers. Key Points

Early Prostate Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:

More information

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.

More information

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer

Breast Cancer. CSC Cancer Experience Registry Member, breast cancer ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.

More information

Bristol Hospital Cancer Care Center 2015 Annual Report

Bristol Hospital Cancer Care Center 2015 Annual Report Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the

More information

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate

More information

Breast Cancer Follow-Up

Breast Cancer Follow-Up Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Breast Cancer Follow-Up Breast Cancer Follow-Up Version 2002: Thomssen / Scharl Version 2003 2009: Bauerfeind / Bischoff /

More information

Common Medical Malpratice Delayed Diagnosis Cases: Melanoma

Common Medical Malpratice Delayed Diagnosis Cases: Melanoma DELAYED DIAGNOSIS SKINCANCER Common Medical Malpratice Delayed Diagnosis Cases: Melanoma Melanoma makes up the smallest percentage of skin cancer cases, yet it s the deadliest form causing the greatest

More information

Nicole Kounalakis, MD

Nicole Kounalakis, MD Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations

More information

SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA SQUAMOUS CELL CARCINOMA What are the aims of this leaflet? This leaflet has been written to help you understand more about squamous cell carcinomas of the skin. It tells you what they are, what causes

More information

See MP/H rules on the slides if you do not have your manual.

See MP/H rules on the slides if you do not have your manual. Quiz 1 1. Which of the following statements about the incidence of melanoma in the US over the last 30 years is true? a. Melanoma incidences have been going down for both men and women. b. Melanoma incidences

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

Statistics fact sheet

Statistics fact sheet Statistics fact sheet Fact sheet last updated January 2015 EXTERNAL VERSION Macmillan Cancer Support Page 1 of 10 Macmillan and statistics Statistics are important to Macmillan because they help us represent

More information

LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA

LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA LUNG CANCER the new Staging System G.KIROVA TOKUDA HOSPITAL SOFIA STAGING SYSTEM Provides standardized nomenclature for exchanging information Groups patients according to the biologic behavior of their

More information

Loco-regional Recurrence

Loco-regional Recurrence Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch

More information

Cancer doesn t care but we do. 2010 Cancer Annual Report

Cancer doesn t care but we do. 2010 Cancer Annual Report Cancer doesn t care but we do. 2010 Cancer Annual Report The Cancer Committee of CHRISTUS St. Patrick Hospital is proud to present its 2010 Annual Report. The Community Hospital Comprehensive Cancer Program

More information

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding

More information

FAMILY PHYSICIANS AND THEIR ROLE IN TREATING SKIN TUMORS

FAMILY PHYSICIANS AND THEIR ROLE IN TREATING SKIN TUMORS FAMILY PHYSICIANS AND THEIR ROLE IN TREATING SKIN TUMORS By: Kaitlin Fulmore Home for the Summer program: June 13 to July 22, 2016 Stonewall, Manitoba Supervisor: Dr. Greg Pinniger Preamble This summer

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

2012 Oncology Service Line Goals and Accomplishments

2012 Oncology Service Line Goals and Accomplishments 2012 Oncology Service Line Goals and Accomplishments 2012 Program goals and outcomes Quality and Service Seek NAPBC accreditation by December 31, 2012 Application was accepted; visit date set for April

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER

2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER 2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER Humboldt County is located on the Redwood Coast of Northern California. U.S census data for 2010 reports county population at 134,623, an increase of

More information

Cancer Diagnosis and Staging

Cancer Diagnosis and Staging Cancer diagnosis and Staging Module 4 Cancer Diagnosis and Staging Target Audience: Community members Staff of Indian health programs, including Community Health Representatives Contents of Learning Module:

More information

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision

More information

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public

More information

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

Colon cancer in patients 40 years old or younger

Colon cancer in patients 40 years old or younger BUMC Proceedings 1998;11:175-178 Colon cancer in patients 40 years old or younger ROBERT E. FARNER, MD, TAMMY L. FISHER, RN, ROBERT M. JACOBSON, MD, PAITOON TULANON, MD, EDWARD R. FRANKO, MD, R. D. DIGNAN,

More information

Stage IV Renal Cell Carcinoma. Changing Management in A Comprehensive Community Cancer Center. Susquehanna Health Cancer Center

Stage IV Renal Cell Carcinoma. Changing Management in A Comprehensive Community Cancer Center. Susquehanna Health Cancer Center Stage IV Renal Cell Carcinoma Changing Management in A Comprehensive Community Cancer Center Susquehanna Health Cancer Center 2000 2009 Warren L. Robinson, MD, FACP January 27, 2014 Introduction 65,150

More information

Melanoma The Skin Understanding Cancer

Melanoma The Skin Understanding Cancer Melanoma A form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or

More information

BREAST CANCER RISK ASSESSMENT. Prof Greta Dreyer University of Pretoria

BREAST CANCER RISK ASSESSMENT. Prof Greta Dreyer University of Pretoria BREAST CANCER RISK ASSESSMENT Prof Greta Dreyer University of Pretoria Age-standardised death rates from breast cancer by country (per 100,000 inhabitants). no data less than 2 2-4 4-6 6-8 8-10 10-12 12-14

More information

Specific Standards of Accreditation for Residency Programs in Plastic Surgery

Specific Standards of Accreditation for Residency Programs in Plastic Surgery Specific Standards of Accreditation for Residency Programs in Plastic Surgery INTRODUCTION 2008 The purpose of this document is to provide program directors and surveyors with an interpretation of the

More information

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

Prostate Cancer. Screening and Diagnosis. Screening. Pardeep Kumar Consultant Urological Surgeon

Prostate Cancer. Screening and Diagnosis. Screening. Pardeep Kumar Consultant Urological Surgeon The Royal Marsden Prostate Cancer Screening and Diagnosis Pardeep Kumar Consultant Urological Surgeon Prostate Cancer Screening and Diagnosis 08 02 2013 2 Screening 1 3 Q1.Lots of men have prostate cancer

More information

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia? La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia? Paola Pisani Registro Tumori Infantili Piemonte Università

More information

Skin Cancer Awareness

Skin Cancer Awareness Skin Cancer Awareness Guest Expert: Girardi, MD www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed Chu and Dr. Francine, I am Bruce Barber. Dr. Chu is Deputy Director

More information

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James

More information

Focussing on Inequalities: Variation in breast cancer outcomes with age and deprivation

Focussing on Inequalities: Variation in breast cancer outcomes with age and deprivation Focussing on Inequalities: Variation in breast cancer outcomes with age and deprivation West Midlands Cancer Intelligence Unit ACKNOWLEDGEMENTS ACKNOWLEDGEMENTS Acknowledgements ACKNOWLEDGEMENTS The authors

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

Sentinel Lymph Node Biopsy: Questions and Answers. Key Points

Sentinel Lymph Node Biopsy: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Sentinel Lymph Node Biopsy:

More information

POSITION STATEMENT. Screening and early detection of skin cancer. Recommendations. Screening. * Endorsed by the Australasian College of Dermatologists

POSITION STATEMENT. Screening and early detection of skin cancer. Recommendations. Screening. * Endorsed by the Australasian College of Dermatologists POSITION STATEMENT Screening and early detection of skin cancer * Endorsed by the Australasian College of Dermatologists Cancer Council Australia and the Australasian College of Dermatologists do not endorse

More information

Endometrial Cancer Treatment

Endometrial Cancer Treatment Endometrial Cancer Treatment January 2006 By Shelly Smits, RHIT, CCS, CTR mary by Ian Thompson, MD Data Source: Cancer registry information on uterine cancer diagnosed 1/1/2000 to 12/31/2004. Reason for

More information